ArticlePublished 28 Feb 2024

Brain Barrier: Knowns and Unknowns in Health and Disease

Authors: Riccardo Tizzoni, Paul Otien, Nathaniel Guarnaccia

Journal of Multiple Sclerosis

Volume 11 · Issue 2 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The current study indicates lower Candida levels, possibly influenced by factors like geography, lifestyle, diet, or analytical methods. Saccharomyces may play a role in both maintaining a healthy mycobiome and contributing to certain diseases. This suggests a potential strain-specific effect or the broader mycobiome composition's impact on disease development. Further research into the relationship between Saccharomyces, Candida, and other microbiome components in multiple sclerosis is necessary. Investigating fungi's role in disease progression or prevention is crucial. This study provides initial evidence of fungal microbiome disturbance in multiple sclerosis patients, paving the way for future research using advanced sequencing methods and larger sample sizes. Integrating these approaches with mechanistic studies will be essential for understanding fungi's precise role in multiple sclerosis pathobiology.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Multiple Sclerosis
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Riccardo Tizzoni”
  • BylineArticles whose byline prints “Paul Otien”
  • BylineArticles whose byline prints “Nathaniel Guarnaccia”